Here, the treatment with Acivicin or Azaserine altered the secretion profiles of pro-inflammatory cytokines (IL-6 and TNF-α), which are induced under stress conditions, while also increasing the production of anti-inflammatory cytokines (IL-4 and IL-10) as part of a compensatory mechanism to counteract excessive inflammation during tumor development. The gene discussed is IL6; the disease is neoplasm.